New Delhi, March 21 Indian pharmaceutical companies Sun Pharma, Dr Reddy's, and Glenmark announced on Saturday the launch of their generic versions of semaglutide injection, used for diabetes and weight management, following the expiration of patents on products like Ozempic and Wegovy in India...